Electromedical Technologies, Inc
Electromedical Technologies, Inc
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Series B Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | |||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 0 | 0 | 1 | |||||
Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | - | 1 | 1 | 1 | 1 | 1 | |||||
Assets | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||||
Accrued Liabilities And Other Liabilities | - | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 | 0 | |||||
Contract With Customer Liability Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 4 | 4 | 4 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 2 | 1 | |||||
Loans Payable To Bank Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Finance Lease Liability Current | - | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Convertible Debt Current | 1 | - | - | - | - | - | - | - | - | - | - | - | |||||
Operating Lease Liability Current | 0 | - | - | - | - | - | - | - | - | - | - | - | |||||
Derivative Liabilities Current | 1 | 1 | 1 | 1 | 0 | 1 | - | - | - | - | - | - | |||||
Long Term Loans From Bank | - | - | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 | |||||
Liabilities Noncurrent | |||||||||||||||||
Other Loans Payable Long Term | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Finance Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | |||||
Operating Lease Liability Noncurrent | 0 | - | - | - | - | - | - | - | - | - | - | - | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 4 | 3 | 2 | 3 | 2 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | |||||||||||||||||
Additional Paid In Capital | 24 | 24 | 24 | 24 | 24 | 24 | 23 | 22 | 22 | 21 | 20 | 21 | |||||
Stockholders Equity | -4 | -3 | -4 | -3 | -3 | -2 | -1 | -2 | -2 | -1 | -2 | -1 | |||||
Retained Earnings Accumulated Deficit | -29 | -28 | -28 | -27 | -27 | -27 | -25 | -25 | -24 | -23 | -22 | -22 | |||||
Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 5,000 | 5,000 | 1,999 | 1,999 | 1,999 | 1,999 | 1,999 | 999 | 999 | 500 | 500 | 250 | |||||
Shares Outstanding | 725 | 566 | 486 | 463 | 471 | 432 | 297 | 190 | 158 | 142 | 105 | 88 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -10.00% | 0.00% | 33.33% | -42.86% | -61.90% | -52.38% | 0.00% | -25.00% | -50.00% | - | - | - |
| 2023 | -50.00% | -69.23% | -69.23% | -20.00% | -35.00% | -50.00% | -31.82% | -36.36% | -36.36% | 100.00% | 20.00% | 0.00% |
| 2022 | 4.80% | 17.11% | 120.39% | -15.79% | -55.79% | -63.16% | -24.24% | -32.58% | -33.71% | -48.00% | -66.00% | -72.00% |
| 2021 | - | - | - | - | - | - | - | - | - | -34.81% | -65.43% | -60.49% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.07 | 0.10 | 0.10 | 0.13 | 0.18 | 0.28 | 0.64 | 0.22 | 0.28 | 0.17 | 0.20 | 0.47 | |||||
| Quick Ratio | 0.01 | 0.03 | 0.02 | 0.03 | 0.05 | 0.14 | 0.51 | 0.13 | 0.19 | 0.06 | 0.09 | 0.29 | |||||
| Working Capital | -4.05M | -3.44M | -3.73M | -2.91M | -2.55M | -2.27M | -872.31K | -2.28M | -1.78M | -1.36M | -1.75M | -767.40K | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.14 | -1.20 | -1.19 | -1.26 | -1.34 | -1.45 | -2.52 | -1.61 | -1.81 | -1.76 | -1.67 | -2.94 | |||||
| Interest Coverage TTM | -4.38 | -2.57 | -1.70 | -2.31 | -1.88 | -1.97 | -2.22 | -2.03 | -3.20 | -1.49 | -1.20 | -1.15 | |||||
| Debt Ratio | 8.04 | 6.11 | 6.22 | 4.84 | 3.95 | 3.21 | 1.66 | 2.64 | 2.24 | 2.32 | 2.48 | 1.52 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.30 | 1.42 | 1.11 | 1.28 | 1.26 | 1.36 | 0.96 | 0.83 | 0.74 | 0.81 | 0.68 | 0.64 | |||||
| Days Sales Outstanding TTM | 3.26 | 4.57 | 1.35 | 1.87 | 3.33 | 7.04 | 5.25 | 7.07 | 9.02 | 8.00 | 10.17 | 10.62 | |||||
| Receivables Turnover TTM | 112.09 | 79.87 | 270.27 | 194.87 | 109.76 | 51.86 | 69.47 | 51.64 | 40.47 | 45.63 | 35.88 | 34.38 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | - | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 | -0.05 | -0.09 | -0.11 | -0.24 | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 75.08% | 75.87% | 77.11% | 77.51% | 77.97% | 78.32% | 78.47% | 77.28% | 77.98% | 77.58% | 76.60% | 78.04% | |||||
| Operating Profit Margin TTM | -109.62% | -72.21% | -76.03% | -153.09% | -147.80% | -159.68% | -163.75% | -139.46% | -294.41% | -276.10% | -307.57% | -418.83% | |||||
| Net Profit Margin TTM | -182.41% | -110.87% | -240.00% | -196.08% | -226.05% | -276.96% | -221.03% | -311.03% | -804.96% | -1,023.87% | -1,072.37% | -1,350.18% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -35.09% | -12.58% | -3.54% | 17.30% | 47.42% | 39.71% | 35.71% | 26.72% | -9.61% | 1.50% | 6.46% | - | |||||
| Net Income Growth (1Y) | -47.62% | -65.01% | 4.74% | -26.05% | -58.60% | -62.21% | -72.03% | -70.81% | -3.23% | 46.68% | 48.72% | - | |||||
| EPS Growth (1Y) | -64.14% | -79.31% | -45.79% | -73.81% | -86.95% | -87.07% | -88.69% | -88.86% | -64.22% | -54.16% | -56.33% | - | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.20 | -0.23 | -0.13 | -0.10 | -0.10 | -0.07 | -0.42 | -0.25 | -0.20 | -0.18 | -0.38 | -0.28 | |||||
| P/B TTM | -0.09 | -0.09 | -0.11 | -0.09 | -0.13 | -0.12 | -1.16 | -0.40 | -0.87 | -1.36 | -2.32 | -4.70 | |||||
| P/S TTM | 0.37 | 0.26 | 0.31 | 0.20 | 0.23 | 0.19 | 0.92 | 0.78 | 1.57 | 1.81 | 4.09 | 3.74 | |||||
| Market Cap | 340.50K | 311.67K | 395.09K | 264.05K | 326.35K | 268.00K | 1.20M | 895.10K | 1.51M | 1.79M | 3.94M | 3.39M | |||||
| Enterprise Value | 1.70M | 326.30K | 459.68K | 331.29K | 353.98K | -148.25K | -32.19K | 526.67K | 1.06M | 1.72M | 3.77M | 3.01M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -131.21K | -527.87K | -1.42M | -1.72M | -1.70M | -1.60M | -908.23K | -773.34K | -1.03M | -880.95K | -1.18M | -1.19M | |||||
| Net Debt | 1.36M | 14.63K | 64.59K | 67.24K | 27.63K | -416.26K | -1.24M | -368.43K | -458.92K | -65.23K | -170.05K | -383.17K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Electromedical Technologies, Inc (EMED) — SEC Financial Statements & Analysis
Electromedical Technologies, Inc (EMED) is a surgical & medical instruments & apparatus company, incorporated in DE. Electromedical Technologies, Inc trades on OTC as: EMED. Based on its latest SEC filing (Form 10-Q, period ending 2024-09-30), Electromedical Technologies, Inc reported a -35.09% year-over-year revenue growth, a Gross Profit Margin of 75.08% (TTM), a Debt-to-Equity ratio of -1.14x, a Price-to-Sales (P/S) ratio of 0.37x (TTM), a Price-to-Book (P/B) ratio of -0.09x (TTM), at a market cap of $340.50K. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -35.09%
- Gross Profit Margin TTM
- 75.08%
- Debt To Equity
- -1.14x
- P/S TTM
- 0.37x
- P/B TTM
- -0.09x
- Market Cap
- $340.50K
Data as of 2024-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Electromedical Technologies, Inc in?
Electromedical Technologies, Inc (EMED) operates in the Surgical & Medical Instruments & Apparatus industry.
What is EMED's market cap?
Electromedical Technologies, Inc (EMED) has a market capitalization of $340.50K as of 2024-09-30.
What exchange does EMED trade on?
Electromedical Technologies, Inc (EMED) trades on the OTC.
Where is Electromedical Technologies, Inc incorporated?
Electromedical Technologies, Inc is incorporated in DE.